Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Stock Information for Calyxt Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Calyxt Inc.

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Immunotherapy Clinical Trials - A New Approach to Treating Cancer
Aethlon Medical to Present at Virtual Investor Conferences in September
Innovation Driving Cancer's Solid Tumors Market
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial
Aethlon Medical to Present at the Life Sciences Investor Forum September 19th
Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.